38056387|t|Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer's disease.
38056387|a|Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory loss and deficits in cognitive domains. Low choline levels, oxidative stress, and neuroinflammation are the primary mechanisms implicated in AD progression. Simultaneous inhibition of acetylcholinesterase (AChE) and reactive oxygen species (ROS) production by a single molecule may provide a new breath of hope for AD treatment. Here, we describe donepezil-tacrine hybrids as inhibitors of AChE and ROS. Four series of derivatives with a beta-amino alcohol linker were designed and synthesized. In this study, the target compounds were evaluated for their ability to inhibit AChE and butyrylcholinesterase (BuChE) in vitro, using tacrine (hAChE, IC50 = 305.78 nM; hBuChE, IC50 = 56.72 nM) and donepezil (hAChE, IC50 = 89.32 nM; hBuChE, IC50 = 9137.16 nM) as positive controls. Compound B19 exhibited an excellent and balanced inhibitory potency against AChE (IC50 = 30.68 nM) and BuChE (IC50 = 124.57 nM). The cytotoxicity assays demonstrated that the PC12 cell viability rates of compound B19 (84.37 %) were close to that of tacrine (87.73 %) and donepezil (79.71 %). Potential therapeutic effects in AD were evaluated using the neuroprotective effect of compounds against H2O2-induced toxicity, and compound B19 (68.77 %) exhibited substantially neuroprotective activity at the concentration of 25 muM, compared with the model group (30.34 %). Furthermore, compound B19 protected PC12 cells from H2O2-induced apoptosis and ROS production. These properties of compound B19 suggested that it was a multi-functional agent with AChE inhibition, anti-oxidative, anti-inflammatory activities, and low toxicity and that it deserves further investigation as a promising agent for AD treatment.
38056387	54	63	donepezil	Chemical	MESH:D000077265
38056387	64	71	tacrine	Chemical	MESH:D013619
38056387	116	129	neurotoxicity	Disease	MESH:D020258
38056387	138	157	Alzheimer's disease	Disease	MESH:D000544
38056387	159	178	Alzheimer's disease	Disease	MESH:D000544
38056387	180	182	AD	Disease	MESH:D000544
38056387	189	215	neurodegenerative disorder	Disease	MESH:D019636
38056387	245	256	memory loss	Disease	MESH:D008569
38056387	261	290	deficits in cognitive domains	Disease	MESH:D003072
38056387	296	303	choline	Chemical	MESH:D002794
38056387	334	351	neuroinflammation	Disease	MESH:D000090862
38056387	393	395	AD	Disease	MESH:D000544
38056387	436	456	acetylcholinesterase	Gene	83817
38056387	458	462	AChE	Gene	83817
38056387	468	491	reactive oxygen species	Chemical	MESH:D017382
38056387	493	496	ROS	Chemical	MESH:D017382
38056387	567	569	AD	Disease	MESH:D000544
38056387	599	608	donepezil	Chemical	MESH:D000077265
38056387	609	616	tacrine	Chemical	MESH:D013619
38056387	642	646	AChE	Gene	83817
38056387	651	654	ROS	Chemical	MESH:D017382
38056387	690	708	beta-amino alcohol	Chemical	-
38056387	827	831	AChE	Gene	83817
38056387	836	857	butyrylcholinesterase	Gene	65036
38056387	859	864	BuChE	Gene	65036
38056387	882	889	tacrine	Chemical	MESH:D013619
38056387	945	954	donepezil	Chemical	MESH:D000077265
38056387	1038	1041	B19	Chemical	-
38056387	1105	1109	AChE	Gene	83817
38056387	1132	1137	BuChE	Gene	65036
38056387	1162	1174	cytotoxicity	Disease	MESH:D064420
38056387	1204	1208	PC12	CellLine	CVCL:0481
38056387	1242	1245	B19	Chemical	-
38056387	1278	1285	tacrine	Chemical	MESH:D013619
38056387	1300	1309	donepezil	Chemical	MESH:D000077265
38056387	1354	1356	AD	Disease	MESH:D000544
38056387	1426	1430	H2O2	Chemical	MESH:D006861
38056387	1439	1447	toxicity	Disease	MESH:D064420
38056387	1462	1465	B19	Chemical	-
38056387	1620	1623	B19	Chemical	-
38056387	1634	1638	PC12	CellLine	CVCL:0481
38056387	1650	1654	H2O2	Chemical	MESH:D006861
38056387	1677	1680	ROS	Chemical	MESH:D017382
38056387	1722	1725	B19	Chemical	-
38056387	1778	1782	AChE	Gene	83817
38056387	1816	1828	inflammatory	Disease	MESH:D007249
38056387	1849	1857	toxicity	Disease	MESH:D064420
38056387	1926	1928	AD	Disease	MESH:D000544
38056387	Negative_Correlation	MESH:D000077265	MESH:D000544
38056387	Negative_Correlation	MESH:D013619	83817
38056387	Comparison	MESH:D000077265	MESH:D013619
38056387	Negative_Correlation	MESH:D017382	65036
38056387	Negative_Correlation	MESH:D000077265	83817
38056387	Negative_Correlation	MESH:D017382	83817
38056387	Negative_Correlation	MESH:D017382	MESH:D000544
38056387	Negative_Correlation	MESH:D013619	MESH:D000544
38056387	Negative_Correlation	MESH:D013619	MESH:D017382
38056387	Negative_Correlation	MESH:D002794	MESH:D000544
38056387	Negative_Correlation	MESH:D000077265	MESH:D017382
38056387	Association	MESH:D000544	83817

